Open AccessTo Assess the KAP Study about HPV Vaccination among Women of Reproductive Age Group
Author(s) -
G. Shivani,
M. Rajalekshmi
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i48a33245
Subject(s) - medicine , cervical cancer , vaccination , obstetrics and gynaecology , gynecology , family medicine , human papillomavirus , incidence (geometry) , reproductive health , hpv infection , population , obstetrics , demography , pregnancy , cancer , environmental health , immunology , physics , biology , optics , genetics , sociology
Background: Human papillomavirus vaccines prevent infection by certain types of human papillomavirus. HPV vaccine is recommended at age 11-12 years.
Objectives: This study aims to assess the knowledge, attitude and practice about HPV vaccination among Women of reproductive age group.
Materials and Methods: This community based cross sectional study was conducted over a period of three months from January 2021- March 2021 at the Obstetrics and Gynaecology Department OPD at Saveetha Medical College and Hospital. A total of 193 women who attended the Obstetrics and Gynaecology Department were included as study participants. A pretested, semi-structured data tool was used. Descriptive variables were presented as proportions and frequencies. Chi-square test was used to ascertain the associations.
Results: About 55.9% of them had knowledge about HPV vaccination and 52.6% with the risk factors, signs and symptoms, and prevention of cervical carcinoma among the study population.
Conclusion: Advancement of health facilities, encouragement of service provider, sustainable health programs and creating awareness will support to achieve decrease in incidence of cervical cancer.